Status:
COMPLETED
Cabenuva Injection Tracking in CHORUS
Lead Sponsor:
Epividian
Collaborating Sponsors:
AIDS Healthcare Foundation
ViiV Healthcare
Conditions:
HIV Infections
Eligibility:
All Genders
Phase:
NA
Brief Summary
This is a cluster randomized trial in which clinics will be randomized to the intervention or the control arm. The purpose of this study is to assess if receiving alerts can help providers manage the ...
Detailed Description
A novel long-acting HIV antiretroviral therapy has recently been approved by the FDA: cabotegravir and rilpivirine delivered through intramuscular injection. These injections should be administered mo...
Eligibility Criteria
Inclusion
- Inclusion Criteria (patients):
- As per label, routine clinical care
- Inclusion Criteria (clinics):
- AIDS Healthcare Foundation (AHF) Clinic
- HIV primary care clinic
- Minimum of 100 people living with HIV in care with a viral load \<50 copies/mL at the time of randomization (satellites will be included in the count of their parent clinic).
Exclusion
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2022
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT04863261
Start Date
October 1 2021
End Date
July 7 2022
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIDS Healthcare Foundation
Los Angeles, California, United States, 90028